OpenVSafe by OpenVAERS
Search V-safe

EPW-10185-48892

4 vaccinations 7 coded responses 42 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
782 / TX
Registered
2021-01-29
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-01-29
    Registered in v-safe
  2. 2021-01-29
    Dose 1 — Pfizer-BioNTech
  3. 2021-01-29
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  4. 2021-01-30
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain, Swelling · None
    Adult check-in
  5. 2021-01-31
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  6. 2021-02-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-02-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-05
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-12
    Survey response — day 14, dose 1
    MedDRA: Fatigue, Headache, Influenza like illness, Lethargy, Pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Body aches, headache, fatigue, lethargy, flu-like symptoms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-02-19
    Dose 2 — Pfizer-BioNTech
  12. 2021-02-19
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  13. 2021-02-20
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activities
    Free text: I also have neuroendocrine cancer, type 2 diabetes and chronic pancreatitis and I believe the other symptoms are due to these conditions and are not a result of the vaccine... perhaps.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-02-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-02-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  16. 2021-02-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  17. 2021-02-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  18. 2021-02-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-02-26
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  20. 2021-03-05
    Survey response — day 14, dose 2
    MedDRA: Headache — Feeling: Good
    Free text: Have had a persistent headache.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-03-12
    Survey response — day 21, dose 2
    MedDRA: Abdominal pain upper, Decreased appetite, Diarrhoea, Fatigue, Headache, Pancreatitis — Feeling: Fair · Be unable to do your normal daily activities
    Free text: My symptoms are related to my chronic pancreatitis, not the vaccine. They include severe stomach pain, diarrhea, fatigue, loss of appetite, headache.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  22. 2021-03-19
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-03-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-21
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-08-20
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-01
    Dose 3 — Pfizer-BioNTech
  28. 2021-09-30
    Survey response — day 28, dose 3
    MedDRA: Injection site pain, Nausea — Feeling: Good · Be unable to do your normal daily activities
    Free text: Excessive soreness at the injection site. Persisted for several days before finally subsiding. Also felt nauseous for several days following injection.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2021-10-06
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  30. 2021-10-13
    Survey response — day 42, dose 3
    MedDRA: Adverse reaction, Hypokalaemia, Neoplasm malignant — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Symptoms due to cancer treatment and potassium deficiency, not related to vaccine.
    MedDRA releases: 2024-11 · check-in free text available
  31. 2021-12-02
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  32. 2022-03-02
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-05-18
    Dose 4 — Pfizer-BioNTech
  34. 2022-05-19
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  35. 2022-05-20
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness
    Adult check-in
  36. 2022-05-22
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  37. 2022-05-23
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  38. 2022-05-24
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  39. 2022-05-25
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  40. 2022-06-01
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-06-08
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-06-15
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  43. 2022-06-22
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  44. 2022-06-29
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  45. 2022-08-17
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  46. 2022-11-16
    Health check-in — 6 months, dose 4
    Feeling: Good
    Adult check-in
  47. 2023-05-18
    Survey response — 12 months, dose 4
    MedDRA: Hepatic neoplasm, Pre-existing disease — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  48. 2023-05-18
    Report sent to call center — 12 months, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  49. 2023-05-19
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-01-29Pfizer-BioNTech
22021-02-19Pfizer-BioNTech
32021-09-01Pfizer-BioNTech No
42022-05-18Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 4 — day 14, dose 1

2021-02-12

Symptoms: Body aches, headache, fatigue, lethargy, flu-like symptoms.

Release 4 — days 1–6 daily, dose 2

2021-02-20

Systemic reaction (other): I also have neuroendocrine cancer, type 2 diabetes and chronic pancreatitis and I believe the other symptoms are due to these conditions and are not a result of the vaccine... perhaps.

Release 5 — day 14, dose 2

2021-03-05

Symptoms: Have had a persistent headache.

Release 5 — day 21, dose 2

2021-03-12

Symptoms: My symptoms are related to my chronic pancreatitis, not the vaccine. They include severe stomach pain, diarrhea, fatigue, loss of appetite, headache.

Release 9 — day 28, dose 3

2021-09-30

Symptoms: Excessive soreness at the injection site. Persisted for several days before finally subsiding. Also felt nauseous for several days following injection.

Release 10 — day 42, dose 3

2021-10-13

Symptoms: Symptoms due to cancer treatment and potassium deficiency, not related to vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain upper ✓ ✓ ✓
SDAdverse reaction · · ✓
SDDecreased appetite ✓ ✓ ✓
SDDiarrhoea ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHepatic neoplasm · · ✓
SDHypokalaemia · · ✓
SDInfluenza like illness ✓ ✓ ✓
SDInjection site pain · · ✓
SDLethargy ✓ ✓ ✓
SDNausea · · ✓
SDNeoplasm malignant · · ✓
SDPain ✓ ✓ ✓
SDPancreatitis ✓ ✓ ○
SDPre-existing disease · · ✓
SROCondition aggravated ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release